Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51.8Revenue $M0.2Net Margin (%)-10,352.6Z-Score-12.0
Enterprise Value $M38.5EPS $-0.7Operating Margin %-11,437.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-10,352.6Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio5.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-112.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-210.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M79.7ROI % (ttm)-121.7Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CVM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2014-10-13Buy14,999$0.77-15.58view
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.68.33view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.79-17.72view
YOUNG PETER RDirector 2013-06-19Buy25,000$0.24170.83view
KERSTEN GEERT RChief Executive 2013-06-14Buy145,120$0.24170.83view
KERSTEN GEERT RCEO 2013-05-20Buy40,000$0.25160view
KERSTEN GEERT RCEO 2013-05-02Buy118,700$0.27140.74view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy25,000$0.22195.45view
YOUNG PETER RDirector 2013-03-27Buy25,000$0.23182.61view
KERSTEN GEERT RCEO 2013-03-26Buy348,125$0.21209.52view

Press Releases about CVM :

    Quarterly/Annual Reports about CVM:

    News about CVM:

    Articles On GuruFocus.com
    Coverage Initiation Report Focuses on CEL-SCI Corporation Oct 15 2014 
    CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
    CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
    CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
    CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 14 2009 

    More From Other Websites
    NEW STORY CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial with... Dec 08 2014
    CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7... Dec 08 2014
    NEW STORY CEL-SCI Quarterly Patient Enrollment in Its Head and Neck Cancer Phase III Trial Increases... Dec 02 2014
    CEL-SCI Quarterly Patient Enrollment in Its Head and Neck Cancer Phase III Trial Increases Eight... Dec 02 2014
    NEW STORY CEL-SCI Enrolls 22 Patients during October in Its Phase III Immunotherapy Head and Neck... Nov 03 2014
    CEL-SCI Enrolls 22 Patients During October in Its Phase III Immunotherapy Head and Neck Cancer Trial Nov 03 2014
    NEW STORY CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million Nov 02 2014
    CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million Oct 24 2014
    CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Oct 23 2014
    CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Oct 22 2014
    NEW STORY CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and Warrants Oct 21 2014
    NEW STORY CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering Oct 21 2014
    CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering Oct 21 2014
    CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and Warrants Oct 21 2014
    NEW STORY CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants Oct 20 2014
    CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants Oct 20 2014
    CEL-SCI Enrolls 16 Patients in September in Its Phase III Immunotherapy Head and Neck Cancer Trial Oct 03 2014
    Coverage Initiation Report Focuses on CEL-SCI Corporation Oct 01 2014
    CEL-SCI & U.S. Navy Administer Multikine to First Volunteer Patient in Phase I Clinical Trial for... Sep 29 2014
    University of Minnesota Masonic Cancer Center Joins CEL-SCI’s Phase III Head & Neck Cancer Trial Sep 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK